SECTRAL
ACEBUTOLOL HYDROCHLORIDE
Approval overview SECTRAL is listed in Drugs@FDA under application 018917 (NDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ACEBUTOLOL HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PROMIUS PHARMA Submission history Latest submission status date: 2011-03-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview SECTRAL is listed in Drugs@FDA under application 018917 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ACEBUTOLOL HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PROMIUS PHARMA Submission history Latest submission status date: 2011-03-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.